Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Cash: 2023-2024

Historic Change in Cash for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $248.8 million.

  • CG Oncology's Change in Cash rose 67.21% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 94.77%. This contributed to the annual value of $248.8 million for FY2024, which is 411.48% up from last year.
  • Per CG Oncology's latest filing, its Change in Cash stood at $248.8 million for FY2024, which was up 411.48% from -$79.9 million recorded in FY2023.
  • CG Oncology's Change in Cash's 5-year high stood at $248.8 million during FY2024, with a 5-year trough of -$79.9 million in FY2023.
  • Its 2-year average for Change in Cash is $84.5 million, with a median of $84.5 million in 2023.
  • Data for CG Oncology's Change in Cash shows a peak YoY surged of 411.48% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Change in Cash stood at -$79.9 million in 2023, then surged by 411.48% to $248.8 million in 2024.